(PRBuzz.com) January 21, 2013 -- Global Market Direct's pharmaceuticals report, "Baxter Healthcare Corporation - Product Pipeline Review - 2012" provides data on the Baxter Healthcare Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Baxter Healthcare Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Baxter Healthcare Corporation and industry-specific third party sources, put together by Global Markets Direct's team.
------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/511743_baxter_healthcare_corporation_product_pipeline.aspx
------------------------------------------------------------
Scope
* Baxter Healthcare Corporation - Brief Baxter Healthcare Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Baxter Healthcare Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Baxter Healthcare Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Baxter Healthcare Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.
Reasons to Get this Report
* Evaluate Baxter Healthcare Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Baxter Healthcare Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Baxter Healthcare Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Baxter Healthcare Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Baxter Healthcare Corporation and identify potential opportunities in those areas.
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
Baxter Healthcare Corporation Snapshot
Baxter Healthcare Corporation Overview
Key Information
Key Facts
Baxter Healthcare Corporation - Research and Development Overview
Key Therapeutic Areas
Baxter Healthcare Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Combination Treatment Modalities
Baxter Healthcare Corporation - Pipeline Products Glance
Baxter Healthcare Corporation - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Baxter Healthcare Corporation - Drug Profiles
Ross River Virus Vaccine + [aluminum chlorohydrate]
Product Description
Mechanism of Action
R&D Progress
Baxter Healthcare Corporation - Pipeline Products by Route of Administration
Baxter Healthcare Corporation - Dormant Projects
Baxter Healthcare Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Baxter Healthcare Corporation, Recent Developments
Baxter Healthcare Corporation- Press Release
Jul 30, 2012: Shionogi Launches Endoxan Powder 100mg For Oral For Nephrotic Syndrome
Jan 30, 2012: Baxter Announces FDA Approval Of Expanded Indication For TISSEEL For General Hemostasis In Surgery
Financial Deals Landscape
Baxter Healthcare Corporation, Deals Summary
Baxter Healthcare Corporation, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Baxter Healthcare Acquires Rights To AV513 From Avigen
Partnerships
Baxter Healthcare Enters Into Licensing Agreement With Innocoll Pharma
Baxter Healthcare Enters Into Licensing Agreement With Spinal Restoration
Medgenics Extends Co-Development Agreement With Baxter Healthcare
Medgenics Enters Into Co-Development Agreement With Baxter Healthcare
Baxter Healthcare And Capsule Form Partnership To Provide Connectivity Solutions
Baxter Healthcare Signs An Agreement With Nycomed International Management
Baxter Healthcare Signs Agreement With Pfizer
Cadence Pharma Enters Into A Development Agreement With Baxter Healthcare
Halozyme Expands Its Agreement With Baxter Healthcare
Licensing Agreements
Accentia Enters Into Licensing Agreement With Baxter Healthcare
BioVeris Enters Into Technology Licensing Agreement With Baxter Healthcare
BioVeris Enters Into Licensing Agreement With Baxter Healthcare
Asset Transactions
Hikma Pharma Acquires The US Generic Injectables Business From Baxter Healthcare
ZIOPHARM Oncology Acquires Indibulin From Baxter Healthcare
Grifols Acquires Eight Plasma Centres From Biolife Plasma Service
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Baxter Healthcare Corporation, Key Information
Baxter Healthcare Corporation, Key Facts
Baxter Healthcare Corporation - Pipeline by Indication, 2012
Baxter Healthcare Corporation - Pipeline by Stage of Development, 2012
Baxter Healthcare Corporation - Combination Treatment Modalities in Pipeline, 2012
Baxter Healthcare Corporation - Phase III, 2012
Baxter Healthcare Corporation - Pipeline By Route of Administration, 2012
Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=511743&dt=t
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
read full article